Literature DB >> 26898849

Development of a symmetric echo planar imaging framework for clinical translation of rapid dynamic hyperpolarized 13 C imaging.

Jeremy W Gordon1, Daniel B Vigneron1, Peder E Z Larson1.   

Abstract

PURPOSE: To develop symmetric echo planar imaging (EPI) and a reference scan framework for hyperpolarized 13 C metabolic imaging.
METHODS: Symmetric, ramp-sampled EPI with partial Fourier reconstruction was implemented on a 3T scanner. The framework for acquiring a reference scan on the 1 H channel and applied to 13 C data was described and validated in both phantoms and in vivo metabolism of [1-13 C]pyruvate.
RESULTS: Ramp-sampled, symmetric EPI provided a substantial increase in the signal-to-noise ratio of the phantom experiments. The reference scan acquired on the 1 H channel yielded 13 C phantom images that varied in mean signal intensity <2%, compared with 13 C images reconstructed with a reference scan directly measured on the 13 C channel. The structural similarity index and dynamic time course from in vivo 13 C data further support the application of a 1 H reference scan to 13 C data to mitigate Nyquist ghost artifacts.
CONCLUSION: Ramp-sampled, symmetric EPI with spectral-spatial excitation of a single metabolite provides a fast, robust, and clinically efficacious approach to acquire hyperpolarized 13 C dynamic molecular imaging data. The gains of this efficient sampling, combined with partial Fourier methods, enables large matrix sizes required for human studies. Magn Reson Med 77:826-832, 2017.
© 2016 International Society for Magnetic Resonance in Medicine. © 2016 International Society for Magnetic Resonance in Medicine.

Entities:  

Keywords:  echoplanar imaging; hyperpolarized 13C; reference scan; spectroscopic imaging

Mesh:

Substances:

Year:  2016        PMID: 26898849      PMCID: PMC4992668          DOI: 10.1002/mrm.26123

Source DB:  PubMed          Journal:  Magn Reson Med        ISSN: 0740-3194            Impact factor:   4.668


  27 in total

1.  Image quality assessment: from error visibility to structural similarity.

Authors:  Zhou Wang; Alan Conrad Bovik; Hamid Rahim Sheikh; Eero P Simoncelli
Journal:  IEEE Trans Image Process       Date:  2004-04       Impact factor: 10.856

2.  Molecular imaging using hyperpolarized 13C.

Authors:  K Golman; L E Olsson; O Axelsson; S Månsson; M Karlsson; J S Petersson
Journal:  Br J Radiol       Date:  2003       Impact factor: 3.039

Review 3.  Spiral imaging: a critical appraisal.

Authors:  Kai Tobias Block; Jens Frahm
Journal:  J Magn Reson Imaging       Date:  2005-06       Impact factor: 4.813

4.  High-speed spiral-scan echo planar NMR imaging-I.

Authors:  C B Ahn; J H Kim; Z H Cho
Journal:  IEEE Trans Med Imaging       Date:  1986       Impact factor: 10.048

5.  Comparison of acquisition schemes for hyperpolarised ¹³C imaging.

Authors:  Markus Durst; Ulrich Koellisch; Annette Frank; Giaime Rancan; Concetta V Gringeri; Vincent Karas; Florian Wiesinger; Marion I Menzel; Markus Schwaiger; Axel Haase; Rolf F Schulte
Journal:  NMR Biomed       Date:  2015-04-24       Impact factor: 4.044

6.  Motion artifacts in fMRI: comparison of 2DFT with PR and spiral scan methods.

Authors:  G H Glover; A T Lee
Journal:  Magn Reson Med       Date:  1995-05       Impact factor: 4.668

7.  Artifact reduction in EPI with phase-encoded reference scan.

Authors:  X Hu; T H Le
Journal:  Magn Reson Med       Date:  1996-07       Impact factor: 4.668

8.  Concentric rings K-space trajectory for hyperpolarized (13)C MR spectroscopic imaging.

Authors:  Wenwen Jiang; Michael Lustig; Peder E Z Larson
Journal:  Magn Reson Med       Date:  2014-12-22       Impact factor: 4.668

9.  Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C.

Authors:  Charles H Cunningham; Albert P Chen; Mark J Albers; John Kurhanewicz; Ralph E Hurd; Yi-Fen Yen; John M Pauly; Sarah J Nelson; Daniel B Vigneron
Journal:  J Magn Reson       Date:  2007-06-02       Impact factor: 2.229

10.  Metabolic imaging of patients with prostate cancer using hyperpolarized [1-¹³C]pyruvate.

Authors:  Sarah J Nelson; John Kurhanewicz; Daniel B Vigneron; Peder E Z Larson; Andrea L Harzstark; Marcus Ferrone; Mark van Criekinge; Jose W Chang; Robert Bok; Ilwoo Park; Galen Reed; Lucas Carvajal; Eric J Small; Pamela Munster; Vivian K Weinberg; Jan Henrik Ardenkjaer-Larsen; Albert P Chen; Ralph E Hurd; Liv-Ingrid Odegardstuen; Fraser J Robb; James Tropp; Jonathan A Murray
Journal:  Sci Transl Med       Date:  2013-08-14       Impact factor: 17.956

View more
  31 in total

1.  Comparison between 8- and 32-channel phased-array receive coils for in vivo hyperpolarized 13 C imaging of the human brain.

Authors:  Adam W Autry; Jeremy W Gordon; Lucas Carvajal; Azma Mareyam; Hsin-Yu Chen; Ilwoo Park; Daniele Mammoli; Maryam Vareth; Susan M Chang; Lawrence L Wald; Duan Xu; Daniel B Vigneron; Sarah J Nelson; Yan Li
Journal:  Magn Reson Med       Date:  2019-03-29       Impact factor: 4.668

2.  Development of high resolution 3D hyperpolarized carbon-13 MR molecular imaging techniques.

Authors:  Eugene Milshteyn; Cornelius von Morze; Galen D Reed; Hong Shang; Peter J Shin; Zihan Zhu; Hsin-Yu Chen; Robert Bok; Andrei Goga; John Kurhanewicz; Peder E Z Larson; Daniel B Vigneron
Journal:  Magn Reson Imaging       Date:  2017-01-07       Impact factor: 2.546

Review 3.  The use of hyperpolarized carbon-13 magnetic resonance for molecular imaging.

Authors:  Sarmad Siddiqui; Stephen Kadlecek; Mehrdad Pourfathi; Yi Xin; William Mannherz; Hooman Hamedani; Nicholas Drachman; Kai Ruppert; Justin Clapp; Rahim Rizi
Journal:  Adv Drug Deliv Rev       Date:  2016-09-04       Impact factor: 15.470

4.  Coil combination methods for multi-channel hyperpolarized 13C imaging data from human studies.

Authors:  Zihan Zhu; Xucheng Zhu; Michael A Ohliger; Shuyu Tang; Peng Cao; Lucas Carvajal; Adam W Autry; Yan Li; John Kurhanewicz; Susan Chang; Rahul Aggarwal; Pamela Munster; Duan Xu; Peder E Z Larson; Daniel B Vigneron; Jeremy W Gordon
Journal:  J Magn Reson       Date:  2019-02-01       Impact factor: 2.229

Review 5.  Hyperpolarized carbon-13 magnetic resonance spectroscopic imaging: a clinical tool for studying tumour metabolism.

Authors:  Fulvio Zaccagna; James T Grist; Surrin S Deen; Ramona Woitek; Laura Mt Lechermann; Mary A McLean; Bristi Basu; Ferdia A Gallagher
Journal:  Br J Radiol       Date:  2018-01-19       Impact factor: 3.039

Review 6.  Noninvasive Interrogation of Cancer Metabolism with Hyperpolarized 13C MRI.

Authors:  Andrew Cho; Justin Y C Lau; Benjamin J Geraghty; Charles H Cunningham; Kayvan R Keshari
Journal:  J Nucl Med       Date:  2017-06-08       Impact factor: 10.057

7.  Development of methods and feasibility of using hyperpolarized carbon-13 imaging data for evaluating brain metabolism in patient studies.

Authors:  Ilwoo Park; Peder E Z Larson; Jeremy W Gordon; Lucas Carvajal; Hsin-Yu Chen; Robert Bok; Mark Van Criekinge; Marcus Ferrone; James B Slater; Duan Xu; John Kurhanewicz; Daniel B Vigneron; Susan Chang; Sarah J Nelson
Journal:  Magn Reson Med       Date:  2018-01-10       Impact factor: 4.668

8.  Technical Note: A deuterated 13 C-urea reference for clinical multiparametric MRI prostate cancer studies including hyperpolarized pyruvate.

Authors:  Collin J Harlan; Zhan Xu; Keith A Michel; Christopher M Walker; Sanjaya D Lokugama; Gary V Martinez; Mark D Pagel; James A Bankson
Journal:  Med Phys       Date:  2020-05-11       Impact factor: 4.071

Review 9.  Hyperpolarized 13C MRI: State of the Art and Future Directions.

Authors:  Zhen J Wang; Michael A Ohliger; Peder E Z Larson; Jeremy W Gordon; Robert A Bok; James Slater; Javier E Villanueva-Meyer; Christopher P Hess; John Kurhanewicz; Daniel B Vigneron
Journal:  Radiology       Date:  2019-03-05       Impact factor: 11.105

10.  High spatiotemporal resolution bSSFP imaging of hyperpolarized [1-13 C]pyruvate and [1-13 C]lactate with spectral suppression of alanine and pyruvate-hydrate.

Authors:  Eugene Milshteyn; Cornelius von Morze; Jeremy W Gordon; Zihan Zhu; Peder E Z Larson; Daniel B Vigneron
Journal:  Magn Reson Med       Date:  2018-02-16       Impact factor: 4.668

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.